World Investment Advisors bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 764 shares of the biotechnology company’s stock, valued at approximately $454,000.
Other large investors have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 3.7% during the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock worth $1,095,542,000 after buying an additional 65,097 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after buying an additional 812,337 shares during the last quarter. Norges Bank bought a new position in Axon Enterprise in the fourth quarter valued at approximately $482,081,000. Finally, GQG Partners LLC acquired a new stake in Axon Enterprise during the 4th quarter worth $478,349,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Axon Enterprise Stock Up 1.1 %
Axon Enterprise stock opened at $502.55 on Tuesday. The stock has a market capitalization of $38.51 billion, a PE ratio of 129.86, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a 50 day moving average of $580.21 and a 200-day moving average of $556.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Analyst Upgrades and Downgrades
Insider Buying and Selling at Axon Enterprise
In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 6.10% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- Which Wall Street Analysts are the Most Accurate?
- Options Activity Points to More Volatility for Palantir Stock
- What is the Hang Seng index?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- How to buy stock: A step-by-step guide for beginners
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.